MENU
CELC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Celcuity (CELC) Earnings Date & Reports

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology... Show more

A.I. Advisor
published Earnings

CELC is expected to report earnings to rise 34.62% to -104 cents per share on March 19

Celcuity CELC Stock Earnings Reports
Q4'25
Est.
$-1.05
Q3'25
Beat
by $0.10
Q2'25
Missed
by $0.16
Q1'25
Missed
by $0.14
Q4'24
Missed
by $0.04
The last earnings report on November 12 showed earnings per share of -77 cents, beating the estimate of -87 cents. With 1.20M shares outstanding, the current market capitalization sits at 3.65B.
View a ticker or compare two or three
CELC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CELC showed earnings on November 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a biotechnology company develops novel diagnostic tests

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Miscellaneous Commercial Services
Address
16305 36th Avenue North
Phone
+1 763 392-0767
Employees
55
Web
https://www.celcuity.com